Article
Gut Microbiota Modulation through Akkermansia spp . Supplementation Increases CAR T-cell Potency
11 Jun 2025
Abstract excerpt
This study investigates the clinical relevance of the gut microbiome at taxonomic and metabolic levels in anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, both in patients and in a preclinical syngeneic tumor model. Patients with B-cell lymphoma treated with CD19 CAR T cells exhibited profound intestinal dysbiosis, exacerbated after CAR T-cell infusion. This dysbiosis was characterized by low bacterial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
